NASDAQ:KALV - Kalvista Pharmaceuticals News Headlines

Sign in or create an account to add this stock to your watchlist.
$28.20 +0.11 (+0.39 %)
(As of 03/22/2019 04:00 PM ET)
Previous Close$28.20
Today's Range$27.40 - $28.53
52-Week Range$7.73 - $34.92
Volume73,863 shs
Average Volume176,769 shs
Market Capitalization$486.45 million
P/E Ratio-18.43
Dividend YieldN/A
Beta2.45

Headlines

Kalvista Pharmaceuticals (NASDAQ KALV) News Headlines

Source:
DateHeadline
Jefferies Financial Group Analysts Lift Earnings Estimates for Kalvista Pharmaceuticals Inc (KALV)Jefferies Financial Group Analysts Lift Earnings Estimates for Kalvista Pharmaceuticals Inc (KALV)
www.americanbankingnews.com - March 22 at 7:59 AM
Needham sees 24% upside for KalVista in permarket analyst actionNeedham sees 24% upside for KalVista in permarket analyst action
seekingalpha.com - March 20 at 4:16 PM
Kalvista Pharmaceuticals (KALV) Now Covered by Needham & Company LLCKalvista Pharmaceuticals (KALV) Now Covered by Needham & Company LLC
www.americanbankingnews.com - March 20 at 12:17 PM
Insider Selling: Kalvista Pharmaceuticals Inc (KALV) CEO Sells 3,000 Shares of StockInsider Selling: Kalvista Pharmaceuticals Inc (KALV) CEO Sells 3,000 Shares of Stock
www.americanbankingnews.com - March 15 at 11:28 PM
KalVista Pharmaceuticals Inc.KalVista Pharmaceuticals Inc.
www.barrons.com - March 15 at 11:55 AM
Kalvista Pharmaceuticals (KALV) Announces Quarterly  Earnings Results, Beats Expectations By $0.22 EPSKalvista Pharmaceuticals (KALV) Announces Quarterly Earnings Results, Beats Expectations By $0.22 EPS
www.americanbankingnews.com - March 15 at 8:11 AM
Kalvista Pharmaceuticals Inc (KALV) Receives Average Recommendation of "Buy" from BrokeragesKalvista Pharmaceuticals Inc (KALV) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - March 15 at 4:39 AM
Is KalVista Pharmaceuticals’s (NASDAQ:KALV) 147% Share Price Increase Well Justified?Is KalVista Pharmaceuticals’s (NASDAQ:KALV) 147% Share Price Increase Well Justified?
finance.yahoo.com - March 14 at 4:24 PM
Will KalVista Pharmaceuticals Continue to Surge Higher?Will KalVista Pharmaceuticals Continue to Surge Higher?
finance.yahoo.com - March 13 at 11:41 AM
Broadcom (AVGO) to Report Q1 Earnings: What's in the Offing?Broadcom (AVGO) to Report Q1 Earnings: What's in the Offing?
finance.yahoo.com - March 11 at 4:15 PM
Factors Setting the Tone for Oracle's (ORCL) Q3 EarningsFactors Setting the Tone for Oracle's (ORCL) Q3 Earnings
finance.yahoo.com - March 11 at 4:15 PM
$3.97 Million in Sales Expected for Kalvista Pharmaceuticals Inc (KALV) This Quarter$3.97 Million in Sales Expected for Kalvista Pharmaceuticals Inc (KALV) This Quarter
www.americanbankingnews.com - March 11 at 3:32 AM
-$0.45 Earnings Per Share Expected for Kalvista Pharmaceuticals Inc (KALV) This Quarter-$0.45 Earnings Per Share Expected for Kalvista Pharmaceuticals Inc (KALV) This Quarter
www.americanbankingnews.com - March 9 at 11:18 AM
Insider Selling: Kalvista Pharmaceuticals Inc (KALV) Major Shareholder Sells 43,378 Shares of StockInsider Selling: Kalvista Pharmaceuticals Inc (KALV) Major Shareholder Sells 43,378 Shares of Stock
www.americanbankingnews.com - March 6 at 9:17 AM
KalVista Pharmaceuticals Presents Data at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting 2019KalVista Pharmaceuticals Presents Data at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting 2019
finance.yahoo.com - February 25 at 10:53 AM
KalVista Pharmaceuticals (KALV) Announces Brian JG Pereira MD to Board - StreetInsider.comKalVista Pharmaceuticals (KALV) Announces Brian JG Pereira MD to Board - StreetInsider.com
www.streetinsider.com - February 2 at 10:34 AM
KalVista Pharmaceuticals Appoints Brian J. G. Pereira, MD to Board of Directors - Business WireKalVista Pharmaceuticals Appoints Brian J. G. Pereira, MD to Board of Directors - Business Wire
www.businesswire.com - February 1 at 11:10 AM
KalVista up 2% on pipeline updateKalVista up 2% on pipeline update
seekingalpha.com - January 4 at 4:22 PM
KalVista Pharmaceuticals Provides Development Update and 2019 Clinical PlansKalVista Pharmaceuticals Provides Development Update and 2019 Clinical Plans
finance.yahoo.com - January 4 at 8:40 AM
Hedge Funds Are Crazy About KalVista Pharmaceuticals, Inc. (KALV)Hedge Funds Are Crazy About KalVista Pharmaceuticals, Inc. (KALV)
finance.yahoo.com - December 24 at 10:19 AM
BRIEF-Kalvista Pharmaceuticals Reports Fiscal Second Quarter ResultsBRIEF-Kalvista Pharmaceuticals Reports Fiscal Second Quarter Results
www.msn.com - December 14 at 3:58 PM
KalVista Pharmaceuticals (KALV) May Report Negative Earnings: Know the Trend Ahead of Next Weeks ReleaseKalVista Pharmaceuticals (KALV) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
www.nasdaq.com - December 6 at 4:10 PM
KalVista Pharmaceuticals (KALV) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseKalVista Pharmaceuticals (KALV) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - December 6 at 4:10 PM
KalVista Pharmaceuticals (KALV) plans more aggressive development of KVD900KalVista Pharmaceuticals (KALV) plans more aggressive development of KVD900
www.streetinsider.com - November 13 at 9:29 AM
KalVista up 2% on accelerated development plan for lead candidateKalVista up 2% on accelerated development plan for lead candidate
seekingalpha.com - November 12 at 4:09 PM
BRIEF-Kalvista Pharmaceuticals Provides Clinical Update On Kvd900BRIEF-Kalvista Pharmaceuticals Provides Clinical Update On Kvd900
www.msn.com - November 12 at 10:14 AM
KalVista Pharmaceuticals Provides Clinical Update on KVD900KalVista Pharmaceuticals Provides Clinical Update on KVD900
finance.yahoo.com - November 12 at 10:14 AM
KalVista Pharmaceuticals to Present at Upcoming Investor ConferencesKalVista Pharmaceuticals to Present at Upcoming Investor Conferences
finance.yahoo.com - November 6 at 9:46 AM
KalVista To Pioneer Plasma Kallikrein Inhibitor Therapy For Diabetic Macular EdemaKalVista To Pioneer Plasma Kallikrein Inhibitor Therapy For Diabetic Macular Edema
seekingalpha.com - October 3 at 9:43 AM
KalVista Pharmaceuticals to Present at Cantor Global Healthcare ConferenceKalVista Pharmaceuticals to Present at Cantor Global Healthcare Conference
finance.yahoo.com - September 25 at 9:46 AM
Form 4 KalVista Pharmaceuticals For: Sep 18 Filed by: Maetzel AndreasForm 4 KalVista Pharmaceuticals For: Sep 18 Filed by: Maetzel Andreas
www.streetinsider.com - September 21 at 9:35 AM
KalVista Pharmaceuticals (KALV) Reports Q1 Loss of $0.47/ShareKalVista Pharmaceuticals (KALV) Reports Q1 Loss of $0.47/Share
www.streetinsider.com - September 14 at 9:46 AM
Thursday 9/13 Insider Buying Report: KALV, RIGLThursday 9/13 Insider Buying Report: KALV, RIGL
www.nasdaq.com - September 13 at 4:03 PM
Form 4 KalVista Pharmaceuticals For: Sep 10 Filed by: ORONSKY ARNOLD LForm 4 KalVista Pharmaceuticals For: Sep 10 Filed by: ORONSKY ARNOLD L
www.streetinsider.com - September 13 at 9:49 AM
KalVista Pharmaceuticals (KALV) Q1 Earnings Preview: What to Look Out ForKalVista Pharmaceuticals (KALV) Q1 Earnings Preview: What to Look Out For
finance.yahoo.com - September 6 at 3:58 PM
KalVista Pharmaceuticals prices public offering of common stockKalVista Pharmaceuticals prices public offering of common stock
seekingalpha.com - September 6 at 10:01 AM
KalVista Pharmaceuticals Announces Pricing of Public Offering of Common StockKalVista Pharmaceuticals Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - September 6 at 10:01 AM
KalVista Pharmaceuticals Announces Proposed Public Offering of Common StockKalVista Pharmaceuticals Announces Proposed Public Offering of Common Stock
finance.yahoo.com - September 5 at 4:10 PM
Profit-taking pressures KalVista, down 15%Profit-taking pressures KalVista, down 15%
seekingalpha.com - August 24 at 10:24 AM
KalVista Pharmaceuticals advancing pipeline; $14.6M raised; shares up 4%KalVista Pharmaceuticals advancing pipeline; $14.6M raised; shares up 4%
seekingalpha.com - July 31 at 4:10 PM
KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial ResultsKalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results
finance.yahoo.com - July 31 at 9:51 AM
Kalvebod Plc - Series 2 Notice re Coll RedemptionKalvebod Plc - Series 2 Notice re Coll Redemption
finance.yahoo.com - June 30 at 10:19 AM
Kalvebod Plc - Series 2 Notice re Possible RedemptionKalvebod Plc - Series 2 Notice re Possible Redemption
finance.yahoo.com - June 18 at 12:27 PM
KalVista Pharmaceuticals (KALV) Announces Data on KVD900 at 2018 EAACI MeetingsKalVista Pharmaceuticals (KALV) Announces Data on KVD900 at 2018 EAACI Meetings
www.streetinsider.com - May 29 at 4:08 PM
KalVista Pharmaceuticals Presents Data at European Academy of Allergy and Clinical Immunology (EAACI) Congress 2018KalVista Pharmaceuticals Presents Data at European Academy of Allergy and Clinical Immunology (EAACI) Congress 2018
finance.yahoo.com - May 29 at 9:34 AM
KalVista Pharmaceuticals Recognizes HAE DayKalVista Pharmaceuticals Recognizes HAE Day
finance.yahoo.com - May 16 at 10:25 AM
KalVista Pharmaceuticals to Present Data at The Association for Research in Vision and Ophthalmology (ARVO) 2018 ...KalVista Pharmaceuticals to Present Data at The Association for Research in Vision and Ophthalmology (ARVO) 2018 ...
www.businesswire.com - April 20 at 10:03 AM
Management ReportManagement Report
finance.yahoo.com - April 3 at 10:16 AM
KalVista Pharmaceuticals Reports Fiscal Third Quarter Results ... - Business Wire (press release)KalVista Pharmaceuticals Reports Fiscal Third Quarter Results ... - Business Wire (press release)
www.businesswire.com - March 16 at 4:13 PM
KalVista Pharmaceuticals to Present at 30th Annual ROTH ConferenceKalVista Pharmaceuticals to Present at 30th Annual ROTH Conference
finance.yahoo.com - March 5 at 10:59 AM
This page was last updated on 3/23/2019 by MarketBeat.com Staff

Featured Article: What is a Swap?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel